---
ver: rpa2
title: 'GaMNet: A Hybrid Network with Gabor Fusion and NMamba for Efficient 3D Glioma
  Segmentation'
arxiv_id: '2505.05520'
source_url: https://arxiv.org/abs/2505.05520
tags:
- feature
- segmentation
- module
- attention
- features
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: GaMNet addresses the challenge of efficient 3D glioma segmentation
  by integrating Gabor filters with a hybrid neural architecture combining NMamba
  for global modeling and multi-scale CNNs for local feature extraction. The Gabor
  module simulates human visual processing to enhance spatial and frequency feature
  extraction, while the Mixed Feature Extraction module captures both fine-grained
  and contextual information.
---

# GaMNet: A Hybrid Network with Gabor Fusion and NMamba for Efficient 3D Glioma Segmentation

## Quick Facts
- arXiv ID: 2505.05520
- Source URL: https://arxiv.org/abs/2505.05520
- Authors: Chengwei Ye; Huanzhen Zhang; Yufei Lin; Kangsheng Wang; Linuo Xu; Shuyan Liu
- Reference count: 0
- One-line primary result: Achieves 88.35% Dice, 4.32 HD95 on BraTS2023 while maintaining 47.4M parameters and 2539.5G Flops.

## Executive Summary
GaMNet addresses the challenge of efficient 3D glioma segmentation by integrating Gabor filters with a hybrid neural architecture combining NMamba for global modeling and multi-scale CNNs for local feature extraction. The Gabor module simulates human visual processing to enhance spatial and frequency feature extraction, while the Mixed Feature Extraction module captures both fine-grained and contextual information. The Biological Neural Feature Fusion module integrates Gabor and neural features, and the Quadruple Attention module refines lesion-specific features across multiple dimensions. On the BraTS2023 dataset, GaMNet achieves a Dice score of 88.35%, HD95 of 4.32, FNR of 0.07, and FPR of 0.01, outperforming state-of-the-art methods while maintaining only 47.4M parameters and 2539.5G Flops.

## Method Summary
GaMNet is a 3D U-Net-based hybrid architecture that combines handcrafted Gabor filters with learned neural features for glioma segmentation. The network processes multi-modal MRI inputs through a Gabor module that extracts spatial and frequency features, then fuses these with CNN and NMamba features in the Biological Neural Feature Fusion module. The Mixed Feature Extraction module processes features through parallel multi-scale convolutions and NMamba layers for local and global feature capture. A Quadruple Attention module refines lesion-specific features across channel-height-width-depth dimensions. The architecture is trained end-to-end on BraTS2023 and FLARE2022 datasets using SGD with poly learning rate scheduling, achieving state-of-the-art performance with relatively low computational cost.

## Key Results
- Achieves 88.35% Dice and 4.32 HD95 on BraTS2023 glioma segmentation
- Demonstrates 90.70% Dice and 4.91 HD95 on FLARE2022 abdominal CT segmentation
- Maintains only 47.4M parameters and 2539.5G Flops while outperforming larger models
- Shows best FNR (0.07) and FPR (0.01) among compared methods on BraTS2023

## Why This Works (Mechanism)

### Mechanism 1
- Claim: Integrating Gabor filters with learned neural features enhances texture and edge discrimination in glioma boundaries where tumor tissue resembles healthy tissue.
- Mechanism: Gabor filters (biologically motivated by retinal ganglion cells, LGN, and V1) extract multi-scale, multi-orientation spatial and frequency features. The BNFF module fuses these handcrafted features with learned CNN/Mamba features via parallel global aggregation and squeeze-and-excitation branches.
- Core assumption: Glioma boundaries exhibit frequency/texture signatures distinguishable from healthy tissue that pure learned features may miss.
- Evidence anchors:
  - [abstract]: "The Gabor module simulates human visual processing to enhance spatial and frequency feature extraction"
  - [section 2.2]: "These filters extract features across scales and orientations in both spatial and frequency domains... In the frequency domain, they effectively distinguish textures by responding to local frequency variations"
  - [section 3.4]: "removing Gabor filters slightly reduces performance (Dice: 88.18, HD95: 4.41)"
- Break condition: If tumor texture is homogeneous with surrounding tissue across all scales/orientations, Gabor contribution diminishes to noise.

### Mechanism 2
- Claim: Combining NMamba's global sequential modeling with multi-scale CNN's local extraction captures both fine-grained boundaries and long-range anatomical context.
- Mechanism: The MFE module processes input through parallel branches—MSC (1×1×1, 3×3×3, 5×5×5 convolutions) for hierarchical local features, and NMamba for global dependencies via state-space modeling with linear complexity. Outputs are normalized and fused via element-wise addition.
- Core assumption: Glioma segmentation requires both local edge precision and global context (e.g., anatomical priors) that neither CNN nor Mamba alone optimally provides.
- Evidence anchors:
  - [abstract]: "integrating the NMamba module for global modeling and a multi-scale CNN for efficient local feature extraction"
  - [section 2.2]: "NMamba module extracts global features with fewer parameters and lower complexity... fused via addition to integrate multi-scale and contextual information"
  - [section 3.4]: "Excluding the Multi Scale Convolution (MSC) causes a larger drop (Dice: 87.25)... Removing NMamba yields a Dice of 87.41"
  - [corpus]: Weak—neighbor papers (ECMNet, MS-UMamba) show CNN-Mamba hybrid promise but lack direct glioma validation.
- Break condition: If global context provides no discriminative signal for the task, NMamba adds computational overhead without benefit.

### Mechanism 3
- Claim: Quadruple Attention's cross-dimensional interactions reduce false positives/negatives by emphasizing lesion regions across channel-height-width-depth axes simultaneously.
- Mechanism: QA generates four attention branches via tensor permutations—(H,C,W,D), (W,C,H,D), (D,C,H,W), (C,H,W,D)—the first three associate channel with spatial dimensions, the fourth highlights spatial features. Averaging reduces single-axis bias.
- Core assumption: Glioma features exhibit non-local correlations across multiple dimensions that single-axis attention misses.
- Evidence anchors:
  - [abstract]: "Quadruple Attention module refines lesion-specific features across multiple dimensions"
  - [section 2.4]: "Traditional attention mechanisms often overlook spatial-channel interactions due to limited dimensional focus... Averaging all branches reduces reliance on any one and improves robustness"
  - [section 3.4]: "Removing QA [yields] 88.13" (smaller drop than MSC/NMamba but still measurable)
- Break condition: If discriminative signal is concentrated in one dimension, cross-dimensional attention introduces noise.

## Foundational Learning

- Concept: **Gabor Filters and Biological Vision Motivation**
  - Why needed here: The paper grounds its design in human visual processing (RGC→LGN→V1). Understanding why Gabors model V1 receptive fields clarifies the module's purpose.
  - Quick check question: Can you explain why a Gabor filter's Gaussian-envelope cosine structure responds to oriented edges at specific frequencies?

- Concept: **State Space Models (SSM/Mamba) for Sequence Modeling**
  - Why needed here: NMamba relies on Mamba's selective scan mechanism for linear-complexity long-range modeling. Understanding SSMs (state propagation, discretization) is prerequisite to debugging the global branch.
  - Quick check question: How does Mamba achieve linear complexity in sequence length compared to Transformers' quadratic attention?

- Concept: **Channel and Spatial Attention Mechanisms**
  - Why needed here: FCSA and QA both leverage attention—FCSA uses parallel channel/spatial attention; QA extends to cross-dimensional. Understanding squeeze-excitation, CBAM-style attention is assumed.
  - Quick check question: What does channel attention learn vs. spatial attention, and why would combining them help tumor localization?

## Architecture Onboarding

- Component map:
  Input (multi-modal MRI) → Gabor Module → BNFF Module → Encoder Blocks
                                                              ↓
                                          MFE (MSC + NMamba) per stage
                                                              ↓
                                          FCSA within NMamba branch
                                                              ↓
  Skip Connections → QA Module ← ← ← ← ← Intermediate Features
                           ↓
                       Decoder + Upsampling
                           ↓
                       Segmentation Output

- Critical path: Input → Gabor → BNFF (fusion) → MFE (local+global) → QA (skip refinement) → Decoder. Errors propagate most severely through BNFF (early fusion) and MFE (core representation).

- Design tradeoffs:
  - **Gabor vs. pure learned features**: Adds interpretability and texture sensitivity but introduces hyperparameters (λ, θ, φ, σ, γ) and fixed filters.
  - **NMamba vs. Transformer**: Linear complexity enables larger 3D volumes, but Mamba's state propagation can lose early-sequence information—hence FCSA integration to preserve critical features.
  - **QA's 4-branch design**: More comprehensive than triplet attention but increases permutation/computation overhead (~4× attention computation).

- Failure signatures:
  - **Over-smoothed boundaries**: MSC kernel sizes may be too coarse; try adding 1×1×1 path or reducing 5×5×5.
  - **Missed small lesions (high FNR)**: NMamba's flattening to 1D may lose spatial locality; verify FCSA is preserving spatial weights.
  - **False positives in healthy tissue (high FPR)**: Gabor filters may respond to non-tumor texture; inspect filter responses on negative samples.

- First 3 experiments:
  1. **Ablation baseline**: Replicate Table VII results—train full model, then remove each component (Gabor, MSC, NMamba, FCSA, BNFF, QA) individually. Confirm Dice drops match reported values (±0.5%).
  2. **Gabor scale sensitivity**: Vary λ and σ across 2–3 configurations; visualize filter responses on sample glioma slices to confirm edge/texture activation aligns with tumor boundaries.
  3. **NMamba sequence order test**: Test alternative flatten orders (H×W×D vs. D×H×W) to verify whether scan order affects global context preservation on BraTS validation split.

## Open Questions the Paper Calls Out

### Open Question 1
- Question: Can the integration of non-imaging data, such as clinical reports or genomics, further improve the segmentation accuracy and clinical applicability of GaMNet?
- Basis in paper: [explicit] The conclusion states, "Future work will explore integrating MRI with other modalities... and non-imaging data (e.g., clinical reports, genomics) to further improve accuracy."
- Why unresolved: The current study validates the model exclusively using imaging data (MRI and CT) from BraTS2023 and FLARE22 datasets.
- What evidence would resolve it: Experiments demonstrating performance changes when multimodal non-imaging patient data is fused with the visual features extracted by GaMNet.

### Open Question 2
- Question: Does the specific flattening strategy used in the NMamba module effectively preserve 3D spatial dependencies compared to multi-directional scanning?
- Basis in paper: [inferred] The paper states the NMamba module "reshapes the 3D feature data into a 1D long sequence," claiming it minimizes perceptual bias, but provides no comparative analysis against other state-space scanning strategies.
- Why unresolved: Flattening 3D volumes to 1D can potentially disrupt local spatial continuity, yet the paper does not ablate this specific design choice against alternatives (e.g., 3D-scan or cross-scan mechanisms).
- What evidence would resolve it: An ablation study comparing the current flattening approach with other Mamba scanning patterns on 3D medical segmentation tasks.

### Open Question 3
- Question: Does the efficiency of GaMNet translate to real-time inference speeds on mobile medical devices?
- Basis in paper: [inferred] The abstract posits that the model targets "real-time use on mobile medical devices," but all experiments were conducted on a high-performance NVIDIA RTX3090 GPU.
- Why unresolved: While the model has relatively low parameter counts (47.4M) and FLOPs, actual latency on resource-constrained mobile hardware (CPU/Mobile GPU) is not reported.
- What evidence would resolve it: Benchmarks of inference time (ms/voxel) and memory footprint on edge devices or embedded systems commonly used in clinical settings.

## Limitations

- Architectural hyperparameters for Gabor filters (λ, θ, φ, σ, γ) and NMamba implementation details are unspecified, preventing exact replication.
- The claim of "superior segmentation accuracy and efficiency" relies on comparison to unspecified state-of-the-art methods beyond the mentioned baselines.
- Cross-dataset generalization from brain MRI (BraTS) to abdominal CT (FLARE) may overstate architectural robustness without domain-specific validation.

## Confidence

- **High confidence**: The Gabor-CNN-Mamba hybrid architecture is technically sound and well-motivated by biological vision principles and recent efficiency-focused architectures (ECMNet, MS-UMamba).
- **Medium confidence**: Reported metrics (88.35% Dice, 4.32 HD95) are internally consistent with ablation trends, but baseline comparisons lack methodological transparency.
- **Low confidence**: Claims about "human visual processing simulation" and "biologically neural feature fusion" are qualitative assertions without quantitative validation of Gabor filter contributions beyond ablation.

## Next Checks

1. Implement and test ablation studies to verify reported Dice drops when removing Gabor (0.17), MSC (1.10), and NMamba (0.94) components.
2. Conduct head-to-head comparison against published 3D U-Net, Swin UNETR, and SegMamba implementations on identical BraTS2023 splits with identical preprocessing.
3. Analyze Gabor filter responses on tumor vs. healthy tissue samples to verify the claimed frequency/texture discrimination capability.